Consequently, loss of E-cadherin function or expression during tumor progression as a consequence of the epithelial to mesenchymal transition results in the translocation of CTNND1 from cell membrane to the cytoplasm and/or the nucleus [33–37]. Here, CTNND1 is linked to neoplasm.